Country selection and data sources
Figure1 illustrates the cumulative number of reported COVID-19 cases and the incidence of malaria infection in Africa. The four countries are located in eastern Africa, western Africa, and central and southern Africa, where the infection risk of both COVID-19 and malaria is relatively high. First, to estimate the epidemiological parameters of COVID-19 in each country, we use the time series of cumulative COVID-19 cases in each country till June 2, 2020. The reported COVID-19 cases in each country are collected from the website of the World Health Organization (Source: https://covid19.who.int/). Then, we characterize the annual pattern of malaria transmission potential in each country based on the historical values of VCAP from January 1, 2004, to December 31, 2019. The values of VCAP are downloaded from the International Research Institute for Climate and Society (Source: http://iridl.ldeo.columbia.edu/maproom/Health/Regional/Africa/Malaria/VCAP/index.html). Finally, to quantify the impact of COVID-19 pandemic on malaria transmission potential, we have also collected the population size, the ITN coverage, and the total number of ITNs available for each country. Based on the Malaria Indicator Survey (MIS) in each country, the ITN coverage rate before 2020 is estimated by the percentage of de facto household population who slept under an ITN the night before the survey. While the total number of ITNs available in 2020 can be obtained from the Malaria Operational Plan (FY 2019) of each country. All data and their sources are summarized in Table1.
An illustration of the cumulative number of reported COVID-19 cases and the incidence of malaria infection in Africa. The left shows the total number of reported COVID-19 cases till June 30, 2020. The right shows the incidence of malaria infection (per 1000 population at risk) in 2018. The figure was generated using the Free Software R with version 3.6.3
To accurately predict the trend of COVID-19 pandemic, we first estimate the epidemiological parameters of COVID-19 by fitting the time series of reported COVID-19 cases in each country. Here, the time series is about the reported date of the COVID-19 infections as of June 2, 2020. Evidence has shown that asymptomatic infections play essential roles in the spread of COVID-19. However, due to limited public health resources in the four countries in Africa, it is difficult to identify asymptomatic infections in the early stages of the epidemic. In this case, following existing studies[26, 27], we resort to the classical susceptibleexposedinfectiousremoved (SEIR) model to simulate the transmission dynamics of COVID-19 in a population of size N:
$$begin{aligned} {left{ begin{array}{ll} frac{dS(t)}{dt} = - frac{R_0}{D_I} cdot frac{ S(t) I(t)}{N}\ frac{dE(t)}{dt} = frac{R_0}{D_I} cdot frac{ S(t) I(t)}{N} - frac{E(t)}{D_E} \ frac{dI(t)}{dt} = frac{E(t)}{D_E} - frac{I(t)}{D_I} \ frac{dR(t)}{dt} = frac{I(t)}{D_I} end{array}right. } end{aligned}$$
(1)
where S(t), E(t), I(t), and R(t) represent the number of susceptible, exposed, infectious, and removed individuals at time t. In this study, we assume that the reported COVID-19 cases are removed or quarantined from the population and can no longer infect others. Along this line, the time series of reported cases we observed is actually the states of R(t) over time.
There are three epidemiological parameters in the SEIR model: (R_0) is the basic reproduction number; (D_E) is the average latent period; and (D_I) is the average contagious period (i.e., the average duration that an infectious individual is confirmed to be infected). Following the study in[26], we assume that the latent period is the same as the incubation period. Further, based on the estimation in[1], the mean incubation period of COVID-19 was 5.2 days. In this case, we set (D_E=5.2). The infectious rate, (beta =R_0/D_I), controls the rate of spread that represents the probability of transmitting disease between a susceptible and an infectious individual. In this study, we adopt the particle Markov Chain Monte Carlo method to estimate epidemiological parameters (R_0) and (D_I) in each country by fitting the time series of the cumulative number of reported COVID-19 cases[16, 20].
We implement the PMCMC method and simulate the COVID-19 epidemic using python programming language version 3.8.5 (source: https://www.python.org/). We assume that the first exposed case [i.e., E(0)] appears d days before the date of the first reported case in each country. According to the Bayesian inference method, uninformative uniform priors are assigned to model parameters to reduce their influence on the posteriors, that is, (R_0 sim U(0,8)), (D_I sim U(1,20)), and (d sim U(0,30)). Since the interval of each prior covers almost all possible values of the corresponding parameter, such settings have little effect on the inference results as long as the number of iterations is enough. With careful pre-testing, we set the proposal distribution of each parameter to be normal distribution: (q(R_0^{*}|R_0)=norm(R_0^{*}|R_0,0.5)), (q(D_I^{*}|D_I)=norm(D_I^{*}|D_I,0.5)), and (q(d^{*}|d)=norm(d^{*}|d,0.5)). After initializing the values of model parameters as (R_0=2.5), (D_I=5), and (d=14), we run the PMCMC algorithm with 200 particles for 100,000 iterations. Finally, the posterior of each parameter is built upon the last (80%) iterations with a discarded burn-in of 20,000 iterations.
Based on the estimated model parameters, we simulate the dynamics of COVID-19 under two groups of NPIs: (1) contact restriction and social distancing (e.g., contact restrictions and personal preventive actions), and (2) early identification and isolation of cases. Generally speaking, contact restrictions can reduce the infectious rate (beta) of COVID-19; while early identification and isolation of potential cases can reduce the average duration of infection (D_I). On the one hand, we assess the effects of social distancing interventions by reducing the estimated infectious rate (beta) to 25% and 10%, while keeping the duration of infection unchanged. This is equivalent to reducing (R_0) to 25% and 10% of its original value. On the other hand, we also evaluate the impact of combined intervention strategies, where both social distancing and early identification and isolation are implemented. Specifically, the epidemic dynamics of COVID-19 are simulated when reducing (R_0) to 25% and (D_I) to 2 (or 4) at the same time. In addition to what types of NPIs are implemented, it is also important when to implement the interventions. Accordingly, we further simulate the epidemic dynamics of COVID-19 under various settings of NPIs that are implemented on May 18 and June 17, 2020, respectively.
We adopt the notion of vectorial capacity to evaluate malaria transmission potential in malaria-endemic countries in Africa. Based on the Macdonald model[21], the VCAP can be formulated as:
$$begin{aligned} V=frac{ma^2e^{-gn}}{g} = frac{-ma^2p^n}{ln p}, end{aligned}$$
(2)
where m is the average mosquito density per person; a is the expected number of bites on humans per mosquito, per day (i.e., human feeding rate); g is the per-capita daily death rate of a mosquito (i.e., the force of mortality); n is the sporogonic cycle length of the Plasmodium; (p=e^{-g}) represents the probability of a mosquito survives through one whole day. Conceptually, the VCAP incorporates all information about mosquito population (e.g., human biting rate, life expectancy), which is defined as the number of potentially infective contacts a person makes, through the mosquito population, per day. Many studies have shown that the value of VCAP can be calculated based on meteorological factors, such as temperature and precipitation[22, 23]. For example, Ceccato et al. have calculated the average vectorial capacity per 8 days for areas where malaria is considered to be an epidemic in Africa[19]. If there is no abnormal climate change, the annual pattern of malaria transmission potential in each country should be relatively stable across different years. On this basis, we download and extract the 8-day average vectorial capacity for each county from January 1, 2004, to December 31, 2019. We then use the means of the 16-year VCAP as a baseline of the annual pattern of malaria transmission potential.
In this study, we focus mainly on assessing the impact of COVID-19 response on the disruption of ITN distribution, and further on the transmission potential of malaria. Launched in 2005, the Presidents Malaria Initiative (PMI) strives to reduce the burden of malaria across 15 high-burden countries in sub-Saharan Africa through a rapid scale-up of four proven and highly effective malaria prevention and treatment measures, including insecticide-treated mosquito nets. In most countries, the PMI has supported ITN distribution through universal mass campaigns and continuous distribution channels. Based on the Malaria Operational Plan (FY 2019) in each country, we can obtain the total ITNs available from different partner contributions in 2020 (see Table1). In this study, we assume that the available ITNs are distributed throughout the year in a way that the number of distributed ITNs is proportional to the annual pattern of malaria transmission potential in each time interval (eight days in this study). In doing so, the newly increased number of ITNs in a specific time interval t in 2020 can be estimated as:
$$begin{aligned} Delta _i(t) = frac{V_i(t)}{sum _t V_i(t)}Delta _i, end{aligned}$$
(3)
where (Delta _i) represents the total number of available ITNs in country i throughout 2020, and (V_i(t)) represents the mean value of 16-year VCAP in time interval t of each year.
As the number of newly reported COVID-19 cases (Delta _{R_i}(t)=R_i(t)-R_i(t-1)) increases, it is assumed that the distribution of ITNs will be disrupted accordingly. Moreover, when the COVID-19 becomes serious (e.g., the number reaches a threshold value (tau)), the distribution of ITNs will be suspended. Mathematically, we assume that the number of distributed ITNs in time interval t, (D_i(t)), is inversely proportional to the number of reported COVID-19 cases. Thus, we have:
$$begin{aligned} D_i(t) = {left{ begin{array}{ll} (1-Delta _{R_i}(t)/tau )Delta _i(t), &{} text {if } Delta _{R_i}(t) < tau , \ 0, &{} text {otherwise}. end{array}right. } end{aligned}$$
(4)
Let (D_i(1:t)= sum _t D_i(t)) represent the cumulative number of distributed ITNs from the first time interval to the tth interval in 2020. Then, the newly increased ITN coverage rate till time interval t becomes (D_i(1:t)/N_i), where (N_i) is the population size of country i. For case studies in each of the four African countries, the threshold value (tau) is set to be the number of reported cases when various NPIs are implemented.
The disruption or cessation of distribution of ITNs may reduce the expected ITN coverage in a country, which may lead to the increase in human feeding rate a, as well as the transmission potential of malaria. Denote (C_i) as the ITN coverage rate in country i before 2020. In this study, we treat (C_i) as a reference value, which corresponds to human feeding rate of the baseline value of VCAP. Then, if all available ITNs are distributed as expected, the relative change of human feeding rate can be estimated as follows:
$$begin{aligned} r_i^{exp}(t) = frac{1-alpha (C_i+Delta _i(1:t)/N_i)}{1-alpha C_i}, end{aligned}$$
(5)
where (alpha) indicates the efficiency of ITNs against mosquito bites. According to the definition of vectorial capacity, the expected transmission potential of malaria at time interval t can be calculated as:
$$begin{aligned} V_i^{exp}(t) = (r_i^{exp}(t))^2cdot V_i(t). end{aligned}$$
(6)
Similarly, if the distribution of ITNs is disrupted, the relative change of human feeding rate is:
$$begin{aligned} r_i^{dis}(t) = frac{1-alpha (C_i+D_i(1:t)/N_i)}{1-alpha C_i}, end{aligned}$$
(7)
and the transmission potential becomes:
$$begin{aligned} V_i^{dis}(t) = (r_i^{dis}(t))^2cdot V_i(t). end{aligned}$$
(8)
In this study, we set (alpha =1). Note that if the ITN distribution is disrupted, we have (V_i^{exp}(t)
View original post here:
Accessing the syndemic of COVID-19 and malaria intervention in Africa - Infectious Diseases of Poverty - BioMed Central
Related Posts- World Health Organization reference values for human semen characteristics [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Maternal metabolism and obesity: modifiable determinants of pregnancy outcome [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Brain imaging studies of appetite in the context of obesity and the menstrual cycle [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Options for fertility preservation in prepubertal boys [Last Updated On: August 17th, 2024] [Originally Added On: April 6th, 2010]
- Xenografting of testicular tissue from an infant human donor results in accelerated testicular maturation [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Karyotype of miscarriages in relation to maternal weight [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Functional regulation of thymic stromal lymphopoietin on proliferation and invasion of trophoblasts in human first-trimester pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Functional attenuation of human sperm by novel, non-surfactant spermicides: precise targeting of membrane physiology without affecting structure [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Pregnancy outcome in female childhood cancer survivors [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Who should pay for assisted reproductive techniques? Answers from patients, professionals and the general public in Germany [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Sperm donor limits that control for the 'relative' risk associated with the use of open-identity donors [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Long-term cryostorage of sperm in a human sperm bank does not damage progressive motility concentration [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Screening for biomarkers of spermatogonia within the human testis: a whole genome approach [Last Updated On: August 17th, 2024] [Originally Added On: April 14th, 2010]
- Avoiding transgenerational risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Cross border reproductive care in six European countries [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Morphometric dimensions of the human sperm head depend on the staining method used [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- ESX1 gene expression as a robust marker of residual spermatogenesis in azoospermic men [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Innovative virtual reality measurements for embryonic growth and development [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- A longitudinal study of contraception and pregnancies in the same women followed for a quarter of a century [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endometriomas [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Fast-release orodispersible tramadol as analgesia in hysterosalpingography with a metal cannula or a balloon catheter [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Xenotransplantation of cryopreserved human ovarian tissue into murine back muscle [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Predictors of psychological distress in patients starting IVF treatment: infertility-specific versus general psychological characteristics [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Psychological adjustment, knowledge and unmet information needs in women undergoing PGD [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Mothers of IVF and spontaneously conceived twins: a comparison of prenatal maternal expectations, coping resources and maternal stress [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Psychological well-being and sexarche in women with polycystic ovary syndrome [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Is human fecundity declining in Western countries? [Last Updated On: August 17th, 2024] [Originally Added On: May 20th, 2010]
- Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Human studies on genetics of the age at natural menopause: a systematic review [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Current knowledge of the aetiology of human tubal ectopic pregnancy [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Economic contraction and birth outcomes: an integrative review [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Teratogenic mechanisms of medical drugs [Last Updated On: August 17th, 2024] [Originally Added On: June 5th, 2010]
- Levels of semenogelin in human spermatozoa decrease during capacitation: involvement of reactive oxygen species and zinc [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Apoptosis and meiotic segregation in ejaculated sperm from Robertsonian translocation carrier patients [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- In humans, zona pellucida glycoprotein-1 binds to spermatozoa and induces acrosomal exocytosis [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Variants of the EPPIN gene affect the risk of idiopathic male infertility in the Han-Chinese population [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Epidermal clitoral inclusion cysts: not a rare complication of female genital mutilation [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Single versus double intrauterine insemination in multi-follicular ovarian hyperstimulation cycles: a randomized trial [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Obstetric outcomes after transfer of vitrified blastocysts [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Occasional involvement of the ovary in Ewing sarcoma [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Y chromosome microdeletions, sperm DNA fragmentation and sperm oxidative stress as causes of recurrent spontaneous abortion of unknown etiology [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Development and preliminary validation of the fertility status awareness tool: FertiSTAT [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Xenotransplantation of human ovarian tissue to nude mice: comparison between four grafting sites [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Involvement of CFTR in oviductal HCO3- secretion and its effect on soluble adenylate cyclase-dependent early embryo development [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Effect of endometriosis on the protein expression pattern of follicular fluid from patients submitted to controlled ovarian hyperstimulation for in vitro fertilization [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Activin A regulates trophoblast cell adhesive properties: implications for implantation failure in women with endometriosis-associated infertility [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Clinical significance of sperm DNA damage in assisted reproduction outcome [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Fall in implantation rates following ICSI with sperm with high DNA fragmentation [Last Updated On: August 17th, 2024] [Originally Added On: June 17th, 2010]
- Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Fertility after autologous ovine uterine-tubal-ovarian transplantation by vascular anastomosis to the external iliac vessels [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Uterus transplantation in the baboon: methodology and long-term function after auto-transplantation [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Transfer of a selected single blastocyst optimizes the chance of a healthy term baby: a retrospective population based study in Australia 2004-2007 [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Disclosure patterns of mode of conception among mothers and fathers-5-year follow-up of the Copenhagen Multi-centre Psychosocial Infertility (COMPI) cohort [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- A decade of sperm washing: clinical correlates of successful insemination outcome [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Sperm DNA integrity in cancer patients before and after cytotoxic treatment [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- Speriolin is a novel human and mouse sperm centrosome protein [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- No influence of body mass index on first trimester fetal growth [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]
- HLA sharing among couples appears unrelated to idiopathic recurrent fetal loss in Saudi Arabia [Last Updated On: August 17th, 2024] [Originally Added On: July 21st, 2010]